Keyphrases
Tumor Necrosis Factor-α
100%
Skeletal muscle
100%
Peroxisome Proliferator-activated Receptor-γ coactivator-1α (PGC-1α)
100%
LPS-induced Inflammation
100%
PGC-1
100%
Low-grade Inflammation
27%
Acute Inflammation
27%
Whole-body
18%
Anti-inflammatory Properties
9%
Type 2 Diabetic Patients
9%
Peroxisome Proliferator-activated Receptor
9%
Protective Effect
9%
Quadriceps muscle
9%
Coactivator
9%
Anti-inflammatory Effect
9%
Lifestyle-related Disease
9%
Intraperitoneal Injection
9%
Protein Level
9%
Knock-in Mouse Model
9%
MRNA Level
9%
Overexpression
9%
Immunology and Microbiology
Skeletal Muscle
100%
Tumor Necrosis Factor
100%
Muscle
36%
Acute Inflammation
27%
Blood Plasma
27%
Knockout Mouse
9%
Antiinflammatory Activity
9%
Body Weight
9%
Peroxisome
9%
Neuroscience
Skeletal Muscle
100%
Messenger RNA
60%
Blood Plasma
60%
Anti-Inflammatory
40%
Peroxisome Proliferator-Activated Receptor
20%
Intraperitoneal Injection
20%
Biochemistry, Genetics and Molecular Biology
Skeletal Muscle
100%
Tumor Necrosis Factor
100%
Messenger RNA
27%
Blood Plasma
27%
Peroxisome Proliferator-Activated Receptor
9%
Knockout Mouse
9%
Antiinflammatory Activity
9%
Body Weight
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Inflammation
54%
Messenger RNA
27%
Antiinflammatory Activity
9%
Intraperitoneal Injection
9%
Table Salt
9%
Diseases
9%
Anti-Inflammatory Drug
9%
Infection
9%
Peroxisome Proliferator Activated Receptor
9%
Non Insulin Dependent Diabetes Mellitus
9%
Knockout Mouse
9%